Spectral AI Inc. (NASDAQ: MDAI) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT SPECTRAL AI INC.

Spectral AI Inc. (NASDAQ: MDAI)
Listen to this Section


$1.99
+0.0450 ( +2.32% ) 299.5K

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Market Data


Open $1.99
Previous Close $1.94
Volume 299.5K
Market Cap $61.74M
Day Range $1.86 - $2.02
52 Week Range $1.18 - $3.21
Shares Outstanding 31.82M
Change % +2.32%
Net Change ▲ 0.0450
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryMedical/Dental Instruments
IPO Year2023
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -1,423,922.00

Date Type Amount Purchased Purchaser
2024-05-17 Sale -6000.00 SPANGENBERG ERICH
2024-05-14 Buy 2000.00 DiMaio John Michael
2024-05-14 Sale -10000.00 Micek Stan
2024-05-13 Sale -29411.00 Carlson Peter M
2024-05-13 Sale -6084.00 Sparks Jeremiah A.
2024-05-13 Sale -45000.00 SPANGENBERG ERICH
2024-05-13 Sale -10000.00 Capone Vincent S.
2023-11-22 Buy 1000.00 DiMaio John Michael
2023-11-20 Sale -14650.00 Cotton Richard John
2023-09-14 Sale -23278.00 Thatcher Jeffrey Edward

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 62 Nov 13, 2025
8-k 8K-related 22 Oct 24, 2025
10-q Quarterly Reports 61 Aug 13, 2025
8-k 8K-related 15 Aug 13, 2025
8-k 8K-related 15 Jun 30, 2025
4 Insider transactions 1 Jun 10, 2025
4 Insider transactions 1 Jun 06, 2025
8-k 8K-related 16 Jun 03, 2025

Latest News


× Before browsing our site, please accept our cookies policy